Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement.
about
Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycinA comparison of the properties of two classes, C4A and C4B, of the human complement component C4Cell-free synthesis of the fourth component of guinea pig complement (C4): identification of a precursor of serum C4 (pro-C4)Interaction between the third complement protein and cell surface macromoleculesComplement-fixing activity of rheumatoid synovial fluid.C1r deficiency: an inborn error associated with cutaneous and renal disease.Specific inactivation of the fourth complement component. I. In vivo studies.Specific inactivation of the fourth complement component. II. In vitro studies.Structural polymorphism of the fourth component of human complementThe complement system in renal homograft recipents.Activation of complement by opportunist pathogens and chemotypes of Salmonella minnesotaInteractions of radio-detoxified Escherichia coli endotoxin preparations with the complement system.Activation of complement by cell surface components of Staphylococcus aureus.Dichotomy between opsonization and serum complement activation by encapsulated staphylococci.Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man.Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarctionEffect of corticosteroids on the human monocyte IgG and complement receptorsRole of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites.Ontogeny of the human complement system: in vitro biosynthesis of individual complement components by fetal tissuesThe complement system in bullous pemphigoid. I. Complement and component levels in sera and blister fluids.C2 deficiency. Development of lupus erythematosusThe association of respiratory infection, recurrent hematuria, and focal glomerulonephritis with activation of the complement system in the cold.Human lymphocytes bear membrane receptors for C3b and C3dThe effect of Bacillus Calmette-Guerin-induced macrophage activation on the in vivo clearance of sensitized erythrocytes.In vitro synthesis of a regulator of mammalian gene expression.A comparative analysis of the C1-binding ability of fragments derived from complement-fixing and noncomplement-fixing IgM proteins.The chromosomal order of genes controlling the major histocompatibility complex, properdin factor B, and deficiency of the second component of complement.Mechanism of complement-mediated activation of human blood platelets in vitro: comparison of normal and paroxysmal nocturnal hemoglobinuria plateletsElectron spin resonance studies on interaction of complement proteins with erythrocyte membranes.Synthesis of the first component of human complement in vitroFluid phase destruction of C2hu by C1hu. I. Its enhancement and inhibition by homologous and heterologous C4.Fluid phase destruction of C2hu by C1hu. II. Unmasking by C4ihu of C1hu specificity for C2hu.The fixation of complement and the activated first component (C1) of complement by complexes formed between antibody and divalent hapten.Deficiency of C1r in human serum. Effects on the structure and function of macromolecular C1.A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterizationIn vitro studies of complement function in sera of C4-deficient guinea pigs.The antigenic and molecular alterations of C3 in the fluid phase during an immune reaction in normal human serum. Demonstration of a new conversion product, C3xModulation of function of the activated first component of complement by a fragment derived from serum. I. Effect on early components of complementFormation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement.Properdin factor D: characterization of its active site and isolation of the precursor form
P2860
Q24601968-220CDBC5-0A35-4F6F-980F-375B1ECAB8C9Q28266154-B6AD78F4-A93F-4233-9E63-74C4A2801F98Q28270444-CFEC6F2E-9432-409F-88F9-331081E10431Q28610963-93615666-23A9-46A7-B529-5095D8D89E36Q33568264-2141DBA4-E06E-4FB1-ACEE-6B987B8FA7E0Q34068956-AF5DDB99-634D-41BE-8B05-00F36B42A4F3Q34172337-AFBED0C7-AF20-49A1-BFE4-0DE5A0EE24C3Q34176605-CA27DA43-CC50-4663-96C1-00783E4CE10FQ34283625-92FD2CAF-FC50-4BB2-98AE-70D127867F97Q34406882-7DF14389-B9BC-4FEF-8CC7-2AAEC5E7ABC7Q34408610-518576D9-798F-4DF6-B8A8-E11E02070A29Q34428863-516DA08E-6C32-461C-B1D4-487E71D67025Q34444984-4980DAB3-1D05-4F79-980B-4A01E53FEC04Q34447959-1DA95BA8-78A4-47FF-AB78-7751634C240AQ34464887-65A84B9E-5363-4A75-83FF-7AB0807EECBAQ34482115-BF2227ED-58A8-4460-96B9-3C18EF833E4DQ34484295-ACECDCC4-8871-4A5D-86DD-2CCA6303ACC7Q34494201-552F71CE-4EBA-429D-9DD0-57D3D23A3886Q34495300-44E3BA34-F2AB-4E1A-B1E3-973A104F7A31Q34504291-C5294250-04DE-4278-847C-760AD1272F74Q34506917-D81C7D4B-5232-405D-A6C7-B4A0F22E9F83Q34507682-138EE6B1-F0C6-4160-807A-700283EE4EAEQ34516326-4101914B-CE0F-4FF4-A652-C625439AD1A9Q34519797-A3C09BE1-0322-4983-9B1E-B267CABE7206Q34721813-C07CE306-6CC5-4FF0-A3B9-E61420F39B20Q35902222-0E18D4F1-7031-49A6-A802-1332FD152A79Q35905210-1C9AC155-12FC-4F5C-8072-8F3D6669B473Q35905737-5B301C65-A504-4F0A-B57C-855F79B6BFF9Q35995173-62518406-843E-462B-A863-270BD07299A4Q36269370-234395FC-63F6-428F-A123-33B514741607Q36269627-55465C73-BF40-413A-9606-2191D428DA68Q36269993-4F398017-3AF4-45A4-8D1E-88943AB38FAEQ36270162-4B7B7D84-821E-4599-BA73-B3E24FD6A42AQ36270181-0FE8F06B-88CF-4618-861E-0F73B5EE9E1AQ36270487-61B54941-843E-481D-BC02-31ED9BC6D45BQ36271132-69063E52-406F-4305-B2EE-E79F62956068Q36271257-ADC521A7-2157-45BB-9F06-EB1C096B27FAQ36271325-45378BE6-9BD9-4837-80B2-37DEB3237725Q36272704-F4370275-4FA0-4F87-8290-67C7BF09DE24Q36272890-DBCCB0C9-BA6E-4DB1-B286-D15D80961A39
P2860
Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement.
description
1967 nî lūn-bûn
@nan
1967年の論文
@ja
1967年学术文章
@wuu
1967年学术文章
@zh-cn
1967年学术文章
@zh-hans
1967年学术文章
@zh-my
1967年学术文章
@zh-sg
1967年學術文章
@yue
1967年學術文章
@zh
1967年學術文章
@zh-hant
name
Immune hemolysis: a simplified ...... pig or with human complement.
@en
Immune hemolysis: a simplified ...... pig or with human complement.
@nl
type
label
Immune hemolysis: a simplified ...... pig or with human complement.
@en
Immune hemolysis: a simplified ...... pig or with human complement.
@nl
prefLabel
Immune hemolysis: a simplified ...... pig or with human complement.
@en
Immune hemolysis: a simplified ...... pig or with human complement.
@nl
P1476
Immune hemolysis: a simplified ...... a pig or with human complement
@en
P2093
P304
P407
P577
1967-08-01T00:00:00Z